Added to YB: 2024-10-23
Pitch date: 2024-10-22
ECOR [bullish]
electroCore, Inc.
+8%
current return
Author Info
Rogue Funds is a value-oriented hedge fund sharing in-depth analysis. Sign up for the newsletter.
Company Info
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally.
Market Cap
$57.9M
Pitch Price
$9.25
Price Target
N/A
Dividend
N/A
Sector
Health Care Equipment and Supplies
Category
growth
ElectroCore ($ECOR): Amazing Product meets Amazing Management
ECOR: nVNS tech for migraines/cluster headaches. 70% YoY rev growth, 86% GM. FDA-approved gammaCore, military TAC-STIM, consumer Truvaga. VA/Kaiser Network expansion, potential PTSD/addiction indications. Profitability expected H1 2025. $50M mkt cap, severely undervalued vs. growth/potential. Risks: slow Truvaga uptake, failed studies.
Read full article (17 min)